<DOC>
	<DOCNO>NCT01723982</DOCNO>
	<brief_summary>This trial investigate effect FE 200440 compare placebo implantation rate woman undergo IVF/ICSI treatment</brief_summary>
	<brief_title>Barusiban Subcutaneously Reducing Implantation Failure Due Uterine Contractions</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Women age 1837 year Women undergone 24 previous fresh vitro fertilization ( IVF ) intracytoplasmatic sperm injection ( ICSI ) cycle result negative Î²hCG test , despite transfer least one embryo/blastocyst good quality Women current control ovarian stimulation cycle IVF/ICSI follow long Gonadotrophin Releasing Hormone ( GnRH ) agonist GnRH antagonist protocol , receive hCG trigger final follicular maturation undergone oocyte retrieval IVF/ICSI purpose fresh transfer Retrieval least 6 oocyte current control ovarian stimulation cycle Subjects least one embryo good quality available transfer day 3 , least one good quality blastocyst available transfer day 5 A total 6 control ovarian stimulation cycle IVF/ICSI Abnormal karyotype Uterine pathology hydrosalpinx Diagnosed acquire congenital thrombophilia disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>